Inventor · disambiguated record
Jose Manuel Ramos Nieves
Also filed as: RAMOS NIEVES JOSE MANUEL
4 granted patents·7 pending applications·3 citations·filing 2017–2022
61Inventor score
Top patents by PatentIndex Score
11 records- 0189US10609945B2Compositions comprising 2FL and LNnT to control food intake and growth in infants or young childrenNESTEC SA·Filed 2017·Granted Apr 7, 2020·2 cites·15 claims
- 0283US11517579B2Compositions comprising at least one n-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young childrenNESTLE SA·Filed 2018·Granted Dec 6, 2022·1 cites·19 claims
- 0371US12186331B2Compositions comprising at least one n-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young childrenNESTLE SA·Filed 2022·Granted Jan 7, 2025·0 cites·16 claims
- 0467US12403151B2Compositions for use in the promotion of intestinal muscle growth and development and associated intestinal motilityNESTLE SA·Filed 2018·Granted Sep 2, 2025·0 cites·17 claims
- 0560US2022000892A1Infant nutritional composition for use in the enhancement of pancreatic maturation and insulin biosynthesisNESTLE SA·Filed 2019·Application pending·0 cites
- 0649US2022296534A1Scyllo-inositol and b-cell mediated disordersNESTLE SA·Filed 2020·Application pending·0 cites
- 0747US2023218648A1Use of human milk oligosaccharides in nutritional compositions for enhancing bone development and/or bone strengthNESTLE SA·Filed 2021·Application pending·0 cites
- 0844US2022370378A1Scyllo-inositol and its use as insulin sensitizerNESTLE SA·Filed 2020·Application pending·0 cites
- 0940US2021205340A1Compositions comprising sialylated oligosaccharides for use in infants or young children to prevent later in life obesity or related comorbidities and promote a healthy growthNESTEC SA·Filed 2017·Application pending·0 cites
- 1040US2021205341A1Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretionNESTEC SA·Filed 2017·Application pending·0 cites
- 1135US2019029303A1Compositions comprising 2fl and lnnt for use in infants or young children to prevent later in life obesity or related comorbiditiesNESTEC SA·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →